Breaking News
10 hours ago
Vaibhavi M.
Novo reports REDEFINE 4 data as CagriSema shows 23% weight loss but misses non-inferiority vs tirzepatide.
Vaibhavi M.
IDEAYA appoints Dr Theodora Ross as Chief Development Officer to advance its precision oncology pipeline.
Vaibhavi M.
EU approves Sandoz’s Ranluspec ranibizumab biosimilar for multiple retinal diseases.
Vaibhavi M.
Merck restructures Human Health into Oncology and Specialty units, appointing new executive leaders.
Vaibhavi M.